Skip to main content

Advertisement

Table 4 Studies describing HPV and high-risk type-specific prevalence from different countries

From: Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia

Country Study design Test method HPV prevalence Comment Cervical cancer incidence rate per 100 000 [17]a
Denmark
Kjær SK, 2008 [20]
Population-based and opportunistic screening N = 11617
aged 15-93 years
Hybrid capture 2 testing Any - 26.4%
High risk - 23%
HPV peak prevalence at the age 20-24 (50.2%)
Most prevalent high risk HPV 16 (6.0% of all women)
12.6
United Kingdom
Sargent A, 2008 [23]
Routine screening program,
N = 24510
aged 20-64 years
Hybrid capture 2 testing High risk
All ages - 10.6%
20-29 y - 27.3%
30-39 y - 10.3%
40-49 y - 4.2%
50-64 y - 2.5%
Most prevalent high risk HPV 16, 18, 31, 51, 52 8.3
Finland
Leinonen M, 2008 [19]
Population based screening,
N = 16895
aged 25-65 years
Hybrid capture 2 testing High risk - 7.5% High risk HPV peak prevalence at the age 25-29 (24.1%) 4.3
Netherlands
Coupe VMH, 2008 [22]
RC population based screening trial
N = 45362
Aged 18-65
GP5+/6+-PCR EIA High risk - 5.6% High risk peak prevalence at the age 18-24 (21.2%)
Most prevalent high risk HPV 16, 31,18
7.3
Norway
Skjeldestad FE 2008 [21]
N = 898
Aged 16-24 (healthy, non-pregnant, sexually experienced)
PCR HPV 6,11,16,18 - 26%
HPV 16, 18 - 20.8%
HPV 6, 11 - 9.6%
HPV 16 prevalence 16.3%
HPV 18 prevalence
7.3%
10.4
USA
Dunne EF, 2007 [4]
Probability sampling, nationally
representative sample (NHANES 2003-4)
N = 1921
Aged 14-59
PCR Any - 26.8%
High risk - 15.2%
Low risk - 17.8%
HPV peak prevalence at the age 20 to 24 (44.8%)
Most prevalent high risk HPV 53, 52, 59
Most prevalent low risk HPV 62, 84, 89
7.7
Latvia
Silins I, 2004 [35]
Healthy controls from population registry
N = 239
aged 18-89
(cervical cancer risk factor study)
PCR High risk - 8% (HPV 16 and 18 only)   12.9
Russia
Aleksandrova YN, 2000 [36]
Attendants of gynecological clinics
N = 309
reproductive age; lacking the clinical or morphological symptoms of
HPV-related diseases
PCR Any - 29% HPV were overrepresented among women
reporting excessive number of contraceptive abortions
11.9
Three NIS of former Soviet Union
Kulmala SM, 2007 [30]
Consecutive out-patient clinic attendees
N = 3187
(STI clinics n = 722, gynecological patients n = 761, cervical cancer screening n = 1,692)
Hybrid capture 2 testing High risk - 31.2%
* STI clinic - 40.8%,
* gynecological patients - 30.9%,
* screening - 27.2%
Most prevalent high risk HPV 16, 31, 33 NA
Russia
Kulmala SM, 2007 [30]
Consecutive out-patient clinic attendees
N = 1967
Hybrid capture 2 testing High risk - 33.4%, Most prevalent high risk HPV 16, 31,33 11.9
Belarus
Kulmala SM, 2007 [30]
Consecutive out-patient clinic attendees
N = 568
Hybrid capture 2 testing High risk - 27.5%, Most prevalent high risk HPV 16, 33, 31 13.1
Latvia
Kulmala SM, 2007 [30]
Consecutive out-patient clinic attendees
N = 442
Hybrid capture 2 testing High risk - 26.2% Most prevalent high risk HPV 16, 33, 39 12.9
  1. aAge-standardized rate